Senior Research Scientist
Ph.D., Clinical Psychology, Western Reserve University
Dr. Brown has worked in the fields of mental health, criminal justice, and substance abuse as both clinician and researcher for the past 45 years. Dr. Brown joined the staff of the newly formed National Institute on Drug Abuse (NIDA) in 1975 after first serving as clinical psychologist in State and Veterans Administration programs in Ohio, and in the federal penitentiary at Terre Haute, Indiana, as well as acting as the research director for the District of Columbia Department of Corrections, and for the DC Narcotics Treatment Administration. At NIDA he headed up its services research, treatment research, and clinical research programs, as well as developing NIDA’s intramural outpatient research facility and program in Baltimore, Maryland. Later, amidst a hail of confetti and some small arms fire, he returned to NIDA’s extramural program to head up the Institute’s outreach-based HIV prevention program which later was enacted into law on the basis of its success. After leaving NIDA, Dr. Brown joined the staff of the Social Research Center (SRC) of the Friends Research Institute in 1996 as a Senior Investigator. He also holds an adjunct appointment as professor of psychology at the University of North Carolina at Wilmington, and is a consulting scientist with the Institute of Behavioral Research at Texas Christian University. Dr. Brown sits on the editorial boards of several substance abuse journals, and is the author of over 100 articles in refereed journals as well as having written a number of book chapters and edited several books.
His work with the SRC has centered on long-standing interests in the areas of developing and testing aftercare strategies for drug treatment clients generally and for offender clients specifically; examining issues and strategies regarding the recruitment and early engagement in treatment of substance abusers; examining issues and strategies that can further our work in the prevention of HIV and other infectious disease among substance abusers; and developing and testing strategies for achieving the adoption of evidence-based treatments by drug treatment programs. To date, his extraordinarily talented colleagues at the SRC have successfully covered for him and he remains gainfully employed.